(688073)"BIDE PHARMATECH CO., LTD."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 688073 · · 3 pages · Chinese
Summary by 6ix AI
The briefing is scheduled for the end of November and will be conducted online. The company aims to address investor questions regarding its financial results and operational performance during this period.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/688073bide-pharmatech-co-ltdannouncement-on-convening-the-q3-2026-performance-briefing
Bide Pharmatech Co. Ltd. on 6ix
Story so far
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Receipt of Show Cause Notice from the Bangalore Customs of India by Subsidiary
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Conducting Foreign Exchange Hedging Business
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Election of Employee Representative Director for the 3rd Board of Directors
Earlier from Bide Pharmatech
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Receipt of Show Cause Notice from the Bangalore Customs of India by Subsidiary
- (688073)"BIDE PHARMATECH CO., LTD."Report for Q3 2026
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Conducting Foreign Exchange Hedging Business
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
- (688073)"BIDE PHARMATECH CO., LTD."Announcement on Election of Employee Representative Director for the 3rd Board of Directors
Follow Bide Pharmatech into a list and get an email when it puts out news.
Follow Bide Pharmatech